Transforming Technology and Life Sciences Firms for Success in 2021

LinkedIn Share Button Twitter Share Button Other Share Button Other Share Button

Presented on March 22, 2021

Taft Kortus, Principal, Technology Practice
Carisa Wisniewski, Principal, Life Sciences Practice
Dave Copps, CEO and Cofounder, Worlds, Inc.
Michael Macaluso, CEO and Chairman, Ampio Pharmaceuticals
Chris St. Hilaire, CEO and Cofounder, MFour Mobile Research, Inc.

Watch our executive panel discussion on effective approaches that technology and life sciences companies have used to reposition or transform themselves recently to better pursue success in 2021 and beyond. Our guest C-suite speakers at this panel focused on:

  • The implementation of transformational business practices
  • Their organizations’ responses to changes in stakeholder behavior due to COVID-19
  • The solutions they’ve implemented to address their specific operational challenges

Contact Us with Questions

Baker Tilly US, LLP, Baker Tilly Advisory Group, LP and Moss Adams LLP and their affiliated entities operate under an alternative practice structure in accordance with the AICPA Code of Professional Conduct and applicable laws, regulations and professional standards. Baker Tilly Advisory Group, LP and its subsidiaries, and Baker Tilly US, LLP and its affiliated entities, trading as Baker Tilly, are members of the global network of Baker Tilly International Ltd., the members of which are separate and independent legal entities. Baker Tilly US, LLP and Moss Adams LLP are licensed CPA firms that provide assurance services to their clients. Baker Tilly Advisory Group, LP and its subsidiary entities provide tax and consulting services to their clients and are not licensed CPA firms. ISO certification services offered through Moss Adams Certifications LLC. Investment advisory offered through either Moss Adams Wealth Advisors LLC or Baker Tilly Wealth Management, LLC.